Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Clearbridge Health Ltd. ( (SG:1H3) ).
Clearbridge Health Limited held its annual general meeting on 23 April 2026 in Singapore, where shareholders adopted the audited financial statements for the year ended 31 December 2025 and approved directors’ fees of up to S$120,000 for the 2026 financial year. The meeting also saw the re-election of director Mark Benedict Ryan, the retirement of independent director Mah How Soon from the board and its key committees, the re-appointment of CLA Global TS Public Accounting Corporation as auditors, and shareholder approval for broad mandates to issue new shares and grant awards under the company’s performance share plan, reinforcing capital-raising flexibility and long-term incentive alignment.
More about Clearbridge Health Ltd.
Clearbridge Health Limited is a Singapore-incorporated healthcare company listed on SGX Catalist, operating in the medical and health services sector. The group focuses on providing clinical and diagnostic healthcare solutions across Asia, supported by a board and governance structure aligned with local listing rules and corporate regulations.
Technical Sentiment Signal: Sell
Current Market Cap: S$4.3M
See more data about 1H3 stock on TipRanks’ Stock Analysis page.